Wockhardt Limited (NSE:WOCKPHARMA)
1,551.90
-26.30 (-1.67%)
Aug 5, 2025, 1:30 PM IST
Nordstrom Revenue
In the fiscal year ending March 31, 2025, Wockhardt had annual revenue of 30.35B INR with 7.24% growth. Wockhardt had revenue of 7.66B in the quarter ending March 31, 2025, with 4.64% growth.
Revenue
30.35B
Revenue Growth
+7.24%
P/S Ratio
8.45
Revenue / Employee
13.22M
Employees
2,296
Market Cap
256.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 30.35B | 2.05B | 7.24% |
Mar 31, 2024 | 28.30B | 1.73B | 6.51% |
Mar 31, 2023 | 26.57B | -5.73B | -17.74% |
Mar 31, 2022 | 32.30B | 5.22B | 19.28% |
Mar 31, 2021 | 27.08B | -1.36B | -4.78% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 93.60B |
Cipla | 274.80B |
Mankind Pharma | 128.90B |
Apollo Hospitals Enterprise | 217.94B |
Zydus Lifesciences | 232.42B |
Fortis Healthcare | 77.86B |
Aurobindo Pharma | 317.24B |
Wockhardt News
- 22 days ago - Wockhardt shares jump 4% after exiting loss-making US generics business - Business Upturn
- 24 days ago - Wockhardt exits US generics business to focus on innovative portfolio - Business Upturn
- 2 months ago - Senores Pharmaceuticals acquires USFDA-approved ANDA for Enalapril Maleate Tablets from Wockhardt - Business Upturn
- 3 months ago - Senores Pharmaceuticals share price jumps 3% after company acquires ANDA for Topiramate tablets from Wockhardt - Business Upturn
- 3 months ago - Senores Pharmaceuticals acquires ANDA for Topiramate tablets from Wockhardt - Business Upturn
- 4 months ago - Wockhardt shares climb 3% as breakthrough antibiotic Zaynich™ saves US cancer patient with drug-resistant infection - Business Upturn
- 4 months ago - Wockhardt’s novel antibiotic Zaynich™ helps save US child cancer patient battling superbug infection - Business Upturn
- 6 months ago - Wockhardt reports Q3 Results: Revenue up 3% to Rs 721 crore, Net profit at Rs 20 crore vs loss of Rs 86 crore YoY - Business Upturn